Featured Research

from universities, journals, and other organizations

No link found between viral infection and rapidly developing Type 1 diabetes in young children

Date:
May 6, 2013
Source:
Diabetologia
Summary:
Some of the earliest results from the Environmental Determinants of Diabetes in the Young (TEDDY) study - a major Europe-USA consortium exploring the causes of Type 1 diabetes in children -- has found no evidence for viral infection as a cause of the rapid-onset form of the condition.

Some of the earliest results from The Environmental Determinants of Diabetes in The Young (TEDDY) study -- a major Europe-USA consortium exploring the causes of type 1 diabetes in children -- has found no evidence for viral infection as a cause of the rapid-onset form of the condition. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD) and is by Professor Anette-Gabriele Ziegler of the German Research Centre for Environmental Health (Helmholtz Zentrum Mόnchen), Munich, Germany, and colleagues across the USA and Europe, including Drs Hye- Seung Lee and Jeffrey Krischer from the University of South Florida, Tampa, FL, USA, Dr. Thomas Briese from Columbia University, New York, NY, USA, and Dr Beena Akolkar, National Institute of Diabetes and Digestive and Kidney Diseases, USA.

Viral infection could be one of several potential causes of type 1 diabetes, in which the body's own immune system gradually destroys the pancreatic islet beta cells that make insulin -- meaning those affected must take insulin for the rest of their lives. The onset of the disease can be rapid, or take place over many years.

In this new study, the authors assessed whether early viral infection in babies had any association with rapid-onset type 1 diabetes. They analysed initial data from the TEDDY study -- a collaboration between Europe (Finland, Germany, Sweden) and the USA (Washington State, Colorado, Georgia, and Florida). TEDDY's main focus is to identify environmental factors associated with an increased risk for developing autoimmunity and type 1 diabetes.

Between 2004 and 2010, the study screened 420,000 infants younger than 4.5 months and found 21,589 with a genetic predisposition to type 1 diabetes. Families were invited to participate in a prospective collection of detailed infectious, dietary, and developmental data with the hope of identifying environmental factors triggering beta-cell inflammation and diabetes; a total of 8,677 children were enrolled. Of those, 932 had a sibling or parent with type 1 diabetes and 7,745 had no family history. The children visited clinics and had blood taken every 3 months up to age 4 years for detection of markers of beta cell-autoimmunity (islet autoantibodies), presence of viruses, and additional measurements.

The researchers found that 355 children developed islet autoantibodies and 86 of these had progressed to type 1 diabetes by July 2011. Progression time from the appearance of islet autoantibodies to diabetes onset varied, but was rapid and within 6 months in 24 of the children. For 14 of these 24 children, aged between 6 and 24 months, TEDDY researchers had samples of their blood plasma from either side of the time point where autoantibodies first emerged and tested these samples for the presence of viruses using state-of-the-art sequencing. Blood plasma samples from 14 control children, matched for age, study centre and family history of type 1 diabetes were tested in the same manner. Only one of the 14 children who had rapidly progressed to type 1 diabetes had detectable levels of viruses in its plasma samples. This analysis, theoretically capable of detecting all possible known and novel viral agents, found little difference between the cases and the controls.

Progression to diabetes was also not found to be associated with reported infectious episodes analysed in all 24 children who rapidly progressed to diabetes and 72 matched control children. These included recognisable gastrointestinal or respiratory illnesses.

Professor Ziegler says: "These findings cannot exclude the possibility that a causative virus is acquired before the age of 6 months and absent or only present for a brief time in plasma during the months leading to the appearance of beta-cell autoantibodies and progression to diabetes. However, the findings make us again reflect on whether a virus triggers type 1 diabetes."

She adds that one unexpected finding was the lower frequency of fever reported for patients than for controls. She says: "This is a potentially important finding that needs to be substantiated in a larger study. If confirmed, it suggests a protective effect of fever as a marker of more vigorous infection defence and effective virus elimination." Such a study is planned for the entire TEDDY cohort.

She concludes: "Our study of rapid-onset diabetes in early childhood did not provide evidence of viral infection around the time of onset of beta-cell autoimmunity in these children."


Story Source:

The above story is based on materials provided by Diabetologia. Note: Materials may be edited for content and length.


Journal Reference:

  1. H.-S. Lee & T. Briese & C. Winkler & M. Rewers & E. Bonifacio & H. Hyoty & M. Pflueger & O. Simell & J. X. She & W. Hagopian & Å. Lernmark & B. Akolkar & J. P. Krischer & A. G. Ziegler & the TEDDY study group. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia, 2013 DOI: 10.1007/s00125-013-2924-y

Cite This Page:

Diabetologia. "No link found between viral infection and rapidly developing Type 1 diabetes in young children." ScienceDaily. ScienceDaily, 6 May 2013. <www.sciencedaily.com/releases/2013/05/130506191107.htm>.
Diabetologia. (2013, May 6). No link found between viral infection and rapidly developing Type 1 diabetes in young children. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/05/130506191107.htm
Diabetologia. "No link found between viral infection and rapidly developing Type 1 diabetes in young children." ScienceDaily. www.sciencedaily.com/releases/2013/05/130506191107.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins